FDA Adverse Event
Malfunction
Summary report: N
COAGUCHEK ® XS SYSTEM
MDR report key: 4092236
·
Received September 16, 2014
Report
- Report Number
- 1823260-2014-07030
- Event Type
- Malfunction
- Date Received
- September 16, 2014
- Date of Event
- August 17, 2014
- Report Date
- September 18, 2014
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- GJS
- PMA / PMN Number
- K062925
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AZ, US
- Reporter Occupation
- PATIENT
Narratives
Additional Manufacturer Narrative · 1
IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA. CUSTOMER ADVISED THAT SHE USED THE REMAINING STRIPS. THERE ARE NO REMAINING STRIPS TO RETURN. DEVICE WILL NOT BE RETURNED.
Additional Manufacturer Narrative · 1
IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.
Description of Event or Problem · 1
CALLER TESTED 7.1 INR ON THE COAGUCHEK XS SYSTEM WHILE A COMPARISON LAB RETURNED AS 4.3 INR. CUSTOMER'S COUMADIN DOSE WAS LOWERED. CUSTOMER HAD A BLOODY NOSE AT THE TIME OF THE 7.1 INR RESULT. AFTER THE LAB, AN URGENT CARE EMPLOYEE PACKED HER NOSE. NO FURTHER TREATMENT WAS REQUIRED. NO ADVERSE EVENT DUE TO THE DEVICE REPORTED. REQUESTED RETURN OF SUSPECT SYSTEM AND REPLACEMENT WAS SENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 571018 | COAGUCHEK ® XS SYSTEM | PROTHROMBIN TIME TEST STRIPS | GJS | ROCHE DIAGNOSTICS | NA | 21924421 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 062 YR | PLAVIX| COUMADIN |